Announcements and Notices - [Placing / Issue of Shares under a General Mandate]

3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.

Placing Of New Shares Under General Mandate

Proposed Spin-Off And Separate Listing Of
Mandi Inc. On
The Main Board Of The Stock Exchange Of
Hong Kong Limited

Announcements and Notices - [Connected Transaction]

Connected Transaction
Grant Of Awarded Shares By A Subsidiary Of The
Company Pursuant To Its Equity Incentive Plan

Financial Statements/ESG Information - [Interim/Half-Year Report]

2025 Interim Report

Announcements and Notices - [Interim Results]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

3SBio Inc (1530 HK)

Placing Of New Shares Under General Mandate

Proposed Spin-Off And Separate Listing Of Mandi Inc. On The Main Board Of The Stock Exchange Of Hong Kong Limited

Connected Transaction Grant Of Awarded Shares By A Subsidiary Of The Company Pursuant To Its Equity Incentive Plan

2025 Interim Report

Interim Results Announcement For The Six Months Ended 30 June 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)